Conformis/ US20717E2000 /
2023-09-01 9:57:42 PM | Chg. - | Volume | Bid1:50:00 AM | Ask1:50:00 AM | High | Low |
---|---|---|---|---|---|---|
2.2600USD | - | 7,081 Turnover: 13,841.5370 |
2.2400Bid Size: - | 2.2700Ask Size: - | 2.2700 | 2.2500 |
GlobeNewswire
2023-08-23
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the...
GlobeNewswire
2023-08-21
Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger ...
GlobeNewswire
2022-03-14
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire
2022-03-02
Conformis Suspends All Distribution Operations and Business Development in Russia
GlobeNewswire
2022-02-28
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over ...
GlobeNewswire
2022-02-24
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopa...
GlobeNewswire
2022-01-20
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
GlobeNewswire
2022-01-04
Conformis, Inc. to Provide Business Update and Initial Expectations for 2022 on January 6, 2022
GlobeNewswire
2021-12-23
Conformis, Inc. Announces Departure of Chief Legal Officer, Corporate Secretary
GlobeNewswire
2021-11-08
Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant R...
GlobeNewswire
2021-10-04
Conformis, Inc. to Release Third Quarter 2021 Financial Results on November 3, 2021
GlobeNewswire
2021-09-29
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
GlobeNewswire
2021-08-18
Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement Sys...
GlobeNewswire
2021-07-14
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
GlobeNewswire
2021-07-01
Conformis, Inc. to Release Second Quarter 2021 Financial Results on August 4, 2021